Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy
Cells · 2023
DOI: 10.3390/cells12182247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Cristina Marisol Castillo Bautista und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Regenerative Therapies TU Dresden (CRTD), Technische Universität Dresden, 01307 Dresden, Germany. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, European Research Council, DFG Research Center.
Abstract (Originalsprache)
Aging is associated with the disruption of protein homeostasis and causally contributes to multiple diseases, including amyotrophic lateral sclerosis (ALS). One strategy for restoring protein homeostasis and protecting neurons against age-dependent diseases such as ALS is to de-repress autophagy. BECN1 is a master regulator of autophagy; however, is repressed by BCL2 via a BH3 domain-mediated interaction. We used an induced pluripotent stem cell model of ALS caused by mutant FUS to identify a small molecule BH3 mimetic that disrupts the BECN1-BCL2 interaction. We identified obatoclax as a brain-penetrant drug candidate that rescued neurons at nanomolar concentrations by reducing cytoplasmic FUS levels, restoring protein homeostasis, and reducing degeneration. Proteomics data suggest that obatoclax protects neurons via multiple mechanisms. Thus, obatoclax is a candidate for repurposing as a possible ALS therapeutic and, potentially, for other age-associated disorders linked to defects in protein homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Regenerative Therapies TU Dresden (CRTD), Technische Universität Dresden, 01307 Dresden, Germany.
- Core Facility Mass Spectrometry & Proteomics, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307 Dresden, Germany.
- Department of Neurosciences, University of California San Diego, La Jolla, CA 92161, USA.
- Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
- Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
- Institute for Molecular Biology, University of Innsbruck, A-6020 Innsbruck, Austria.
ORCID-Profile: Marc Gentzel, Jerome Mertens, Maximina H Yun, Jared Sterneckert
Förderung
- NIA NIH HHS
- European Research Council
- DFG Research Center
- Cluster of Excellence
- DFG
- German Federal Ministry of Education and Research (BMBF) program ‘Unternehmen Region’
- German Research Foundation
- European Regional Development Fund (ERDF/EFRE)
Zitieren
APA
Castillo Bautista, C. M., Eismann, K., Gentzel, M., Pelucchi, S., Mertens, J., Walters, H. E., Yun, M. H., & Sterneckert, J. (2023). Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy. Cells. https://doi.org/10.3390/cells12182247
Vancouver
Castillo Bautista CM, Eismann K, Gentzel M, Pelucchi S, Mertens J, Walters HE, et al. Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy. Cells. 2023. doi:10.3390/cells12182247
BibTeX
@article{CastilloBautista2023,
author = {Castillo Bautista, Cristina Marisol and Eismann, Kristin and Gentzel, Marc and Pelucchi, Silvia and Mertens, Jerome and Walters, Hannah E and Yun, Maximina H and Sterneckert, Jared},
title = {Obatoclax Rescues FUS-ALS Phenotypes in iPSC-Derived Neurons by Inducing Autophagy},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12182247}
}
EUVIMED